De-Kai Qiu1, Xiong Ma, Yan-Shen Peng, Xiao-Yu Chen. 1. Shanghai Institute of Digestive Diseases, Renji Hospital, Shanghai Second Medical University, Shanghai, 200001, China. dekaiqiu@sh163.net
Abstract
AIM: To clarify the significance of cyclooxygenase-2 (COX-2) expression in human primary hepatocellular carcinoma (HCC) and adjacent nontumorous tissues. METHODS: The COX-2 protein and mRNA were investigated in 27 HCC tissues with adjacent nontumorous tissues, and 5 histologically normal liver tissues,using immunohistochemistry and in situ hybridization. RESULTS: The well-differentiated HCC expressed COX-2 protein (5.68+/-1.19) more strongly than moderated HCC (3.43+/-1.98) and poor differentiated HCC (3.33+/-1.50) (P<0.05 respectively), adjacent nontumorous tissues (4.93+/-1.05) and normal liver tissues (3.20+/-1.92) (P<0.01 respectively); More intensive staining of COX-2 in adjacent nontumorous tissues was observed than that in normal liver tissues (P<0.05). There was no significant difference among adjacent nontumorous tissues, moderately differentiated HCC and poorly differentiated HCC (P>0.05). The expression of COX-2 mRNA was observed in the cytoplasm of the cells of HCC and of the hepatocytes in adjacent nontumorous tissues in which COX-2 protein was positive. CONCLUSION: The overexpression of COX-2 in well-differentiated HCC suggests that COX-2 may play a role in the early stages of hepatocarcinogensis.
AIM: To clarify the significance of cyclooxygenase-2 (COX-2) expression in human primary hepatocellular carcinoma (HCC) and adjacent nontumorous tissues. METHODS: The COX-2 protein and mRNA were investigated in 27 HCC tissues with adjacent nontumorous tissues, and 5 histologically normal liver tissues,using immunohistochemistry and in situ hybridization. RESULTS: The well-differentiated HCC expressed COX-2 protein (5.68+/-1.19) more strongly than moderated HCC (3.43+/-1.98) and poor differentiated HCC (3.33+/-1.50) (P<0.05 respectively), adjacent nontumorous tissues (4.93+/-1.05) and normal liver tissues (3.20+/-1.92) (P<0.01 respectively); More intensive staining of COX-2 in adjacent nontumorous tissues was observed than that in normal liver tissues (P<0.05). There was no significant difference among adjacent nontumorous tissues, moderately differentiated HCC and poorly differentiated HCC (P>0.05). The expression of COX-2 mRNA was observed in the cytoplasm of the cells of HCC and of the hepatocytes in adjacent nontumorous tissues in which COX-2 protein was positive. CONCLUSION: The overexpression of COX-2 in well-differentiated HCC suggests that COX-2 may play a role in the early stages of hepatocarcinogensis.
Authors: S K Boolbol; A J Dannenberg; A Chadburn; C Martucci; X J Guo; J T Ramonetti; M Abreu-Goris; H L Newmark; M L Lipkin; J J DeCosse; M M Bertagnolli Journal: Cancer Res Date: 1996-06-01 Impact factor: 12.701
Authors: H Sano; Y Kawahito; R L Wilder; A Hashiramoto; S Mukai; K Asai; S Kimura; H Kato; M Kondo; T Hla Journal: Cancer Res Date: 1995-09-01 Impact factor: 12.701
Authors: A Denda; T Endoh; W Kitayama; Q Tang; O Noguchi; Y Kobayashi; H Akai; E Okajima; T Tsujiuchi; M Tsutsumi; D Nakae; Y Konishi Journal: Carcinogenesis Date: 1997-10 Impact factor: 4.944
Authors: Soung Won Jeong; Jae Young Jang; Sae Hwan Lee; Sang Gyun Kim; Young Koog Cheon; Young Seok Kim; Young Deok Cho; Hong Soo Kim; Joon Seong Lee; So-Young Jin; Chan Sup Shim; Boo Sung Kim Journal: Korean J Intern Med Date: 2010-11-27 Impact factor: 2.884
Authors: Azza E I El-Bassiouny; Mona M K Zoheiry; Mona M F Nosseir; Eman G El-Ahwany; Raafat A Ibrahim; Nora E I El-Bassiouni Journal: MedGenMed Date: 2007-08-28